Chancroid: Difference between revisions

(Add AntibioticDose entries: Ciprofloxacin, Azithromycin; strip translate tags)
(Add AntibioticDose entries: Ciprofloxacin, Azithromycin)
Line 29: Line 29:
**[[Erythromycin]] 500mg PO QID x7 days '''OR'''
**[[Erythromycin]] 500mg PO QID x7 days '''OR'''
**[[Ciprofloxacin]] 500mg PO BID x3 days
**[[Ciprofloxacin]] 500mg PO BID x3 days
===Antibiotic Dosing===
*{{AntibioticDose|drug=Ciprofloxacin|dose=500mg PO q12h x 3 days|context=Chancroid|disease=Chancroid|population=Adult}}
*{{AntibioticDose|drug=Azithromycin|dose=1 g PO x1|context=Chancroid|disease=Chancroid|population=Adult}}





Revision as of 10:57, 20 March 2026

Background

  • Caused by Haemophilus ducreyi
  • Sexually transmitted
  • Rare in western countries (leads to frequent misdiagnosis in these locations)
Chancroid (male)
Chancroid (female)

Clinical Features

  • Incubation period 3-7 days[1]
  • Lesions begin as soft chancre/papule → painful ulceration with ragged margins[1]
  • Within days to weeks, unilateral painful inguinal lymphadenopathy (buboes) forms
    • These may become abscessed and rupture

Differential Diagnosis

Sexually transmitted diseases

Evaluation

  • Generally clinical diagnosis
  • PCR can be used for indeterminate cases[1]

Management


Antibiotic Dosing


Antibiotic Dosing

Disposition

  • Discharge

See Also

References

  1. 1.0 1.1 1.2 1.3 Basta-Juzbašić A, Čeović R. Chancroid, lymphogranuloma venereum, granuloma inguinale, genital herpes simplex infection, and molluscum contagiosum. Clin Dermatol. 2014 Mar-Apr;32(2):290-8. doi: 10.1016/j.clindermatol.2013.08.013.
  2. https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf

References